Page last updated: 2024-11-01

ondansetron and Bleeding

ondansetron has been researched along with Bleeding in 3 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Zirak, MR1
Karimi, G1
Rahimian, R1
Jafarian, AH1
Hayes, AW1
Mehri, S1
Feng, J1
Sethi, A1
Reyes-Múgica, M1
Antaya, R1
Courtman, SP1
Rawlings, E1
Carr, AS1

Other Studies

3 other studies available for ondansetron and Bleeding

ArticleYear
Tropisetron ameliorates cyclophosphamide-induced hemorrhagic cystitis in rats.
    European journal of pharmacology, 2020, Sep-15, Volume: 883

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Cyclophosphamide; Cystit

2020
Life-threatening blood loss from scratching provoked by pruritus in the bulky perineal nevocytoma variant of giant congenital melanocytic nevus in a child.
    Journal of the American Academy of Dermatology, 2005, Volume: 53, Issue:2 Suppl 1

    Topics: Anal Canal; Anemia; Antipruritics; Child, Preschool; Female; Hemorrhage; Humans; Nevus, Pigmented; O

2005
Masked bleeding posttonsillectomy with ondansetron.
    Paediatric anaesthesia, 1999, Volume: 9, Issue:5

    Topics: Antiemetics; Child; Female; Hemorrhage; Humans; Ondansetron; Postoperative Complications; Postoperat

1999